45
Views
4
CrossRef citations to date
0
Altmetric
Original Article

Cellular Uptake and Antiproliferative Effects of Therapeutic Concentrations of Idarubicin or Daunorubicin and their Alcohol Metabolites, with or without Cyclosporin A, in MDR1+ Human Leukemic Cells

, &
Pages 485-497 | Accepted 30 Aug 1998, Published online: 01 Jul 2009

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Francis J. Giles, Gee C. Wong, Sarah J. Clark, Suerry Pierce, Hagop M. Kantarjian & Michael J. Keating. (2000) Oral Idarubicin in Patients with Late Chronic Phase Chronic Myelogenous Leukemia or Chronic Myelomonocytic Leukemia. Leukemia & Lymphoma 37:1-2, pages 87-95.
Read now

Articles from other publishers (3)

Gianpietro Dotti, Roberto Fiocchi, Teresio Motta, Carmelo Mammana, Eliana Gotti, Silvia Riva, Pieremilio Cornelli, Bruno Gridelli, Piera Viero, Elena Oldani, Paolo Ferrazzi, Giuseppe Remuzzi, Tiziano Barbui & Alessandro Rambaldi. (2002) Lymphomas occurring late after solid-organ transplantation. Transplantation 74:8, pages 1095-1102.
Crossref
R. Bassan, T. Lerede, B. Chiodini, A. Rossi, M. Buelli & T. Barbui. 2001. Acute Leukemias VIII. Acute Leukemias VIII 438 445 .
R. Bassan, A. Z. S. Rohatiner, T. Lerede, M. Carter, E. Di Bona, E. Pogliani, G. Rossi, P. Fabris, S. Morandi, G. Lambertenghi-Deliliers, P. Casula, M. Vespignani, T. A. Lister & T. Barbui. 2001. Acute Leukemias VIII. Acute Leukemias VIII 402 413 .

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.